Jewish studies' lecturer Sampson is an NYC hero

Elissa Sampson, visiting scholar and lecturer in the Jewish Studies Program, will be honored May 18 with a Lower East Side Community Hero Award in New York City.

The Bridge architects talk design, academe and industry

Marion Weiss and Michael A. Manfredi, M.Arch. '80, cofounders of the Weiss/Manfredi architecture and landscape firm, gave an inside look at their design process of The Bridge at Cornell Tech.

Real estate titans talk development in changing world

Students and real estate professionals got a refreshingly honest view of the competitive and contentious world of development April 28 in NYC at a panel discussion.

Cornell Chronicle default image

Class gathers oral histories of Caribbean residents in Brooklyn

Oneka LaBennett's students in oral history and urban ethnography over spring break recorded the life stories of Caribbean immigrants living and working in a rapidly gentrifying part of Brooklyn.

Yimon Aye awarded young investigator cancer research prize

Yimon Aye, assistant professor of chemistry and chemical biology, has won the Pershing Square Sohn Prize for Young Investigators in Cancer Research. The prize is $600,000 over three years.

Collaborative startup will monitor pathogens in hospital settings

Biotia, a startup offering microbial surveillance for hospitals, is a joint venture between researchers at Weill Cornell Medicine and Cornell Tech, founded through the Runway Startup program at the Jacobs Technion-Cornell Institute at Cornell Tech.

MBA students collaborate at Cornell Tech hackathon

One of China's largest online retailers, JD.com, visited the Cornell Tech campus in late April and presented a challenge to 117 Chinese and American MBA students.

Weill Cornell initiative combines financial, medical expertise

A $5 million gift establishes a new initiative that will use predictive tools to enhance Weill Cornell Medicine's capability to diagnose and treat a variety of illnesses to improve outcomes for patients.

Immune cells play crucial role in brain cancer development

Two studies from Weill Cornell Medicine found brain tumors recruit immune cells derived from bone marrow to transform what began as benign masses into deadly malignancies.